BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 36635710)

  • 1. A machine learning framework develops a DNA replication stress model for predicting clinical outcomes and therapeutic vulnerability in primary prostate cancer.
    Huang RH; Hong YK; Du H; Ke WQ; Lin BB; Li YL
    J Transl Med; 2023 Jan; 21(1):20. PubMed ID: 36635710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative multi-omics analysis unveils stemness-associated molecular subtypes in prostate cancer and pan-cancer: prognostic and therapeutic significance.
    Zheng K; Hai Y; Xi Y; Zhang Y; Liu Z; Chen W; Hu X; Zou X; Hao J
    J Transl Med; 2023 Nov; 21(1):789. PubMed ID: 37936202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated machine learning identifies epithelial cell marker genes for improving outcomes and immunotherapy in prostate cancer.
    Zhu W; Zeng H; Huang J; Wu J; Wang Y; Wang Z; Wang H; Luo Y; Lai W
    J Transl Med; 2023 Nov; 21(1):782. PubMed ID: 37925432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The established chemokine-related prognostic gene signature in prostate cancer: Implications for anti-androgen and immunotherapies.
    Chen L; Zheng Y; Jiang C; Yang C; Zhang L; Liang C
    Front Immunol; 2022; 13():1009634. PubMed ID: 36275733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Machine Learning Method for Predicting Biomarkers Associated with Prostate Cancer.
    Tong Y; Tan Z; Wang P; Gao X
    Front Biosci (Landmark Ed); 2023 Dec; 28(12):333. PubMed ID: 38179769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting prostate cancer recurrence: Introducing PCRPS, an advanced online web server.
    He X; Hu S; Wang C; Yang Y; Li Z; Zeng M; Song G; Li Y; Lu Q
    Heliyon; 2024 Apr; 10(7):e28878. PubMed ID: 38623253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prognostic signature consisting of metabolism-related genes and SLC17A4 serves as a potential biomarker of immunotherapeutic prediction in prostate cancer.
    Li H; Gu J; Tian Y; Li S; Zhang H; Dai Z; Wang Z; Zhang N; Peng R
    Front Immunol; 2022; 13():982628. PubMed ID: 36325340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel transcriptomic signature of angiogenesis predicts clinical outcome, tumor microenvironment and treatment response for prostate adenocarcinoma.
    Gu CY; Dai B; Zhu Y; Lin GW; Wang HK; Ye DW; Qin XJ
    Mol Med; 2022 Jul; 28(1):78. PubMed ID: 35836112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Machine-learning predicts time-series prognosis factors in metastatic prostate cancer patients treated with androgen deprivation therapy.
    Saito S; Sakamoto S; Higuchi K; Sato K; Zhao X; Wakai K; Kanesaka M; Kamada S; Takeuchi N; Sazuka T; Imamura Y; Anzai N; Ichikawa T; Kawakami E
    Sci Rep; 2023 Apr; 13(1):6325. PubMed ID: 37072487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen action in the prostate gland.
    Yadav N; Heemers HV
    Minerva Urol Nefrol; 2012 Mar; 64(1):35-49. PubMed ID: 22402316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting poly(ADP-ribose) polymerase and the c-Myb-regulated DNA damage response pathway in castration-resistant prostate cancer.
    Li L; Chang W; Yang G; Ren C; Park S; Karantanos T; Karanika S; Wang J; Yin J; Shah PK; Takahiro H; Dobashi M; Zhang W; Efstathiou E; Maity SN; Aparicio AM; Li Ning Tapia EM; Troncoso P; Broom B; Xiao L; Lee HS; Lee JS; Corn PG; Navone N; Thompson TC
    Sci Signal; 2014 May; 7(326):ra47. PubMed ID: 24847116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted next-generation sequencing of advanced prostate cancer identifies potential therapeutic targets and disease heterogeneity.
    Beltran H; Yelensky R; Frampton GM; Park K; Downing SR; MacDonald TY; Jarosz M; Lipson D; Tagawa ST; Nanus DM; Stephens PJ; Mosquera JM; Cronin MT; Rubin MA
    Eur Urol; 2013 May; 63(5):920-6. PubMed ID: 22981675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Machine learning-derived identification of prognostic signature for improving prognosis and drug response in patients with ovarian cancer.
    Huan Q; Cheng S; Ma HF; Zhao M; Chen Y; Yuan X
    J Cell Mol Med; 2024 Jan; 28(1):e18021. PubMed ID: 37994489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA-Damage-Repair Gene Alterations in Genitourinary Malignancies.
    Dariane C; Timsit MO
    Eur Surg Res; 2022; 63(4):155-164. PubMed ID: 35944490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen deprivation therapy in combination with radiotherapy for high-risk clinically localized prostate cancer.
    Nishiyama T
    J Steroid Biochem Mol Biol; 2012 Apr; 129(3-5):179-90. PubMed ID: 22269996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternations of gene expression in PI3K and AR pathways and DNA methylation features contribute to metastasis of prostate cancer.
    Zhao Y; Hu X; Yu H; Liu X; Sun H; Shao C
    Cell Mol Life Sci; 2022 Jul; 79(8):436. PubMed ID: 35864178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted androgen pathway suppression in localized prostate cancer: a pilot study.
    Mostaghel EA; Nelson PS; Lange P; Lin DW; Taplin ME; Balk S; Ellis W; Kantoff P; Marck B; Tamae D; Matsumoto AM; True LD; Vessella R; Penning T; Hunter Merrill R; Gulati R; Montgomery B
    J Clin Oncol; 2014 Jan; 32(3):229-37. PubMed ID: 24323034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Evaluation of Machine Learning Models and Gene Expression Signatures for Prostate Cancer Prognosis Using Large Population Cohorts.
    Li R; Zhu J; Zhong WD; Jia Z
    Cancer Res; 2022 May; 82(9):1832-1843. PubMed ID: 35358302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecular underpinnings of prostate cancer: impacts on management and pathology practice.
    Rodrigues DN; Boysen G; Sumanasuriya S; Seed G; Marzo AM; de Bono J
    J Pathol; 2017 Jan; 241(2):173-182. PubMed ID: 27753448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.